Abstract:Aim: The purpose of this study was to establish a mode of action for diosgenin against breast cancer employing a range of system biology tools and to corroborate its results with experimental facts. Methodology: The diosgenin-regulated domains implicated in breast cancer were enriched in the Kyoto Encyclopedia of Genes and Genomes database to establish diosgenin-protein(s)-pathway(s) associations. Later, molecular docking and the lead complexes were considered for molecular dynamics simulations, MMPBSA, principal component, and dynamics cross-correlation matrix analysis using GROMACS v2021. Furthermore, survival analysis was carried out for the diosgenin-regulated proteins that were anticipated to be involved in breast cancer. For gene expression analyses, the top three targets with the highest binding affinity for diosgenin and tumor expression were examined. Furthermore, the effect of diosgenin on cell proliferation, cytotoxicity, and the partial Warburg effect was tested to validate the computational findings using functional outputs of the lead targets. Results: The protein-protein interaction had 57 edges, an average node degree of 5.43, and a p-value of 3.83e-14. Furthermore, enrichment analysis showed 36 KEGG pathways, 12 cellular components, 27 molecular functions, and 307 biological processes. In network analysis, three hub proteins were notably modulated: IGF1R, MDM2, and SRC, diosgenin with the highest binding affinity with IGF1R (binding energy -8.6 kcal/mol). Furthermore, during the 150 ns molecular dynamics (MD) projection run, diosgenin exhibited robust intermolecular interactions and had the least free binding energy with IGF1R (-35.143 kcal/mol) compared to MDM2 (-34.619 kcal/mol), and SRC (-17.944 kcal/mol). Diosgenin exhibited the highest cytotoxicity against MCF7 cell lines (IC50 12.05 ± 1.33) µg/ml. Furthermore, in H2O2-induced oxidative stress, the inhibitory constant (IC50 7.68 ± 0.51) µg/ml of diosgenin was lowest in MCF7 cell lines. However, the reversal of the Warburg effect by diosgenin seemed to be maximum in non-cancer Vero cell lines (EC50 15.27 ± 0.95) µg/ml compared to the rest. Furthermore, diosgenin inhibited cell proliferation in SKBR3 cell lines more though. Conclusion: The current study demonstrated that diosgenin impacts a series of signaling pathways, involved in the advancement of breast cancer, including FoxO, PI3K-Akt, p53, Ras, and MAPK signaling. Additionally, diosgenin established a persistent diosgenin-protein complex and had a significant binding affinity towards IGF1R, MDM2, and SRC. It is possible that this slowed down cell growth, countered the Warburg phenomenon, and showed the cytotoxicity towards breast cancer cells.

Inhibition of Diosgenin and Its Analogues Transformed by Streptomyces Virginiae IBL-14 on Human Breast Cancer Cells (bcap37) in Vitro

Design and Synthesis of Novel Dehydroepiandrosterone Analogues As Potent Antiproliferative Agents

23,24-Dihydrocucurbitacin B Induces G2/M Cell-Cycle Arrest and Mitochondria-Dependent Apoptosis in Human Breast Cancer Cells (Bcap37).

Systems and in vitro pharmacology profiling of diosgenin against breast cancer

Diosgenin Induces Cell Cycle Arrest and Apoptosis in Human Leukemia K562 Cells with the Disruption of Ca2+ Homeostasis

Effects of genistein and daidzein on the cell growth, cell cycle, and differentiation of human and murine melanoma cells11The abbreviations used are: BSA, bovine serum albumin; FBS, fetal bovine serum; ECM, extracellular matrix; DMSO, dimethyl sulfoxide; PTK, protein tyrosine kinase.

Effects of Coicis Semen oil on growth of human in situ pancreatic cancer cell line BxPC-3 and expression of VEGF and bFGF

The mitotic-arresting and apoptosis-inducing effects of diosgenyl saponins on human leukemia cell lines.

In Vitro Anti-Cancer Activity of Chamaejasmenin B and Neochamaejasmin C Isolated from the Root of Stellera Chamaejasme L

Anticancer Activity of Diosgenin and Its Molecular Mechanism

Novel diosgenin-1,4-quinone hybrids: Synthesis, antitumor evaluation, and mechanism studies

Biotransformation of Soybean Isoflavones by a Marine Streptomyces Sp. 060524 and Cytotoxicity of the Products

Design and Synthesis of Novel α-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells

Synthesis and Anti-Cancer Activity Studies of Dammarane-Type Triterpenoid Derivatives

Design, Synthesis, And Biological Evaluation Of Hydantoin Bridged Analogues Of Combretastatin A-4 As Potential Anticancer Agents

Dihydroartemisinin-Chloro/Bromoisatin Hybrids: Design, Synthesis, and Anti-Breast Cancer Evaluation

Diosgenyl glucosamine conjugates increase pro‐apoptotic and selective activities in cancer cell lines

Diosgenin inhibits proliferation and migration of ovarian cancer cells and induce apoptosis via upregulation of PTEN

A novel bakuchiol aminoguanidine derivative induces apoptosis in human triple-negative breast cancer cells

Apoptosis Induction of Colorectal Cancer Cells HTL-9 in Vitro by the Transformed Products of Soybean Isoflavones by Ganoderma Lucidum

Design, Synthesis and Preliminary Antiproliferative Activity Studies of New Diheteroaryl Thioether Derivatives